| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.6 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |